Ironwood Pharmaceuticals, Inc.
IRWD
$3.25
-$0.12-3.56%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -200.89% | 999.29% | 2,844.07% | -798.27% | 307.54% |
| Total Depreciation and Amortization | -5.15% | -6.31% | -7.71% | -6.63% | -5.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.70% | 92.36% | -14.25% | -56.03% | 3.41% |
| Change in Net Operating Assets | 315.98% | -128.61% | -632.41% | 50.83% | -298.06% |
| Cash from Operations | 390.17% | 381.37% | -145.03% | -55.64% | -57.54% |
| Capital Expenditure | -- | 87.50% | 96.55% | 54.41% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 87.50% | 96.55% | 54.41% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 40.00% |
| Issuance of Common Stock | -39.90% | -- | -88.25% | -99.94% | -79.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 99.67% |
| Cash from Financing | 100.82% | 100.00% | 100.18% | 100.04% | 70.75% |
| Foreign Exchange rate Adjustments | 1,571.43% | 0.00% | -1,168.63% | -129.17% | 142.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21,465.80% | 374.68% | 2.42% | -32.21% | 101.80% |